Posted on August 27th, 2010 by Health News
Although a cognitive-behavioral intervention to encourage men who have sex with men to reduce their substance use and sexual risk behavior (as both are linked) was partially successful, a similar reduction was achieved in comparison groups who did not receive the intervention suggesting that better methods for changing behaviors are needed…
No Comments »
Filed under: Men's Health
Posted on August 27th, 2010 by Health News
Male infertility is a common medical problem, affecting millions of men in the United States annually. Its causes include an inability to make productive sperm. Now, using yeast as a model organism, researchers at the University of Pennsylvania School of Medicine are beginning to identify the molecular signals that could in part underlie that problem. [...]
No Comments »
Filed under: Men's Health
Posted on August 27th, 2010 by Health News
(MedPage Today) — Medical expenses and costs of lost productivity related to motor vehicle crashes topped $99 billion dollars in a single year, according to CDC investigators.
No Comments »
Filed under: General Health News
Posted on August 27th, 2010 by Health News
WASHINGTON (MedPage Today) — Good news for seniors who want to quit smoking — Medicare will now cover tobacco cessation counseling — the Department of Health and Human Services announced.
No Comments »
Filed under: General Health News
Posted on August 27th, 2010 by Health News
(MedPage Today) — Another type of combination pill for hypertension has won FDA approval — this time putting a direct renin inhibitor together with a calcium channel blocker.
No Comments »
Filed under: Pharmacy News
Posted on August 27th, 2010 by Health News
WASHINGTON (MedPage Today) — The FDA has issued a class I recall, the agency’s most serious, for Huber needles that were found to produce cores — slivers of silicone — when they penetrate a vascular access port.
No Comments »
Filed under: Pharmacy News
Posted on August 27th, 2010 by Health News
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA’s initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab [...]
No Comments »
Filed under: Pharmacy News
Posted on August 27th, 2010 by Health News
An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.
No Comments »
Filed under: Pharmacy News
Posted on August 27th, 2010 by Health News
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
No Comments »
Filed under: Pharmacy News
Posted on August 27th, 2010 by Health News
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
No Comments »
Filed under: Pharmacy News
